Skip to content

CareDx CDNA Return on equity

Return on equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
Natera, Inc. logo
Natera, Inc.NTRA
-29%+4.1pp
NeoGenomics logo
NeoGenomicsNEO
-11.6%+6.2pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-41.4%-6.7pp
GeneDx Holdings logo
GeneDx HoldingsWGS
-30.4%
TransMedics Group, Inc. logo
TransMedics Group, Inc.TMDX
45.2%+22.2pp

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Calculated from CareDx’s reported figures.

Based on trailing twelve months.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's return on equity?
CareDx (CDNA) reported return on equity of -2.4% in Q1 2026.
How has CareDx's return on equity changed year-over-year?
CareDx's return on equity decreased by 112.1% year-over-year, from 19.5% to -2.4%.
What is the long-term trend for CareDx's return on equity?
Over 5 years (2020 to 2025), CareDx's return on equity has grown at a -8.8% compound annual growth rate (CAGR), from -9.9% to -6.3%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.